Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS
· Delayed Price · Currency is USD
0.490
+0.110 (28.95%)
Nov 21, 2024, 4:00 PM EST
Seelos Therapeutics Revenue
Seelos Therapeutics had revenue of $376.00K in the quarter ending June 30, 2024, with 11.90% growth. This brings the company's revenue in the last twelve months to $2.01M, up 76.05% year-over-year. In the year 2023, Seelos Therapeutics had annual revenue of $2.20M.
Revenue (ttm)
2.01M
Revenue Growth
+76.05%
P/S Ratio
0.02
Revenue / Employee
251.75K
Employees
16
Market Cap
215.80K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSeelos Therapeutics News
- 4 weeks ago - Seelos Announces Second Postponement of its Annual Meeting of Stockholders - PRNewsWire
- 5 weeks ago - Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - PRNewsWire
- 2 months ago - Seelos Announces Postponement of its Annual Meeting of Stockholders - PRNewsWire
- 2 months ago - Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - PRNewsWire
- 2 months ago - Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD - PRNewsWire
- 6 months ago - Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - PRNewsWire
- 6 months ago - Seelos Therapeutics Announces 1-for-8 Reverse Stock Split - PRNewsWire
- 7 months ago - Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations - PRNewsWire